CJC-1295 + Ipamorelin: the combination, explained

CJC-1295 + Ipamorelin is a combination supplied in a single vial. This overview explains why the two are paired, with no therapeutic or dosing claims.

What it is

This product combines CJC-1295, a GHRH analogue, with ipamorelin, a ghrelin-receptor agonist. The two act through distinct mechanisms in the growth-hormone-secretagogue landscape, which is exactly why research protocols often study them together.

Why the pairing

Combining a GHRH analogue with a ghrelin-receptor agonist lets a single experiment probe both pathways at once. For the underlying mechanisms, see our growth-hormone-secretagogues overview.

Handling notes

• Supplied lyophilised; reconstitute gently.
• Storage follows the more sensitive component — store conservatively.
• Refrigerate after reconstitution and aliquot for repeated use.

For in-vitro research use only. Not for human or veterinary use.